BioCorRx Inc.
BICX
$0.34
$0.013.03%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 214.50K | -151.10K | 635.20K | 178.20K | 134.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 214.50K | -151.10K | 635.20K | 178.20K | 134.90K |
| Cost of Revenue | 25.20K | -337.00K | 358.80K | -- | -- |
| Gross Profit | 189.40K | 185.90K | 276.40K | 178.20K | 134.90K |
| SG&A Expenses | 775.50K | 539.40K | 1.15M | 1.22M | 886.10K |
| Depreciation & Amortization | 11.20K | -124.80K | 72.00K | 72.00K | 24.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.16M | 383.10K | 2.58M | 1.59M | 1.07M |
| Operating Income | -949.60K | -534.20K | -1.95M | -1.41M | -937.90K |
| Income Before Tax | -859.90K | -471.20K | -808.50K | -1.38M | -851.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -859.90K | -471.20K | -808.50K | -1.38M | -851.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 28.70K | 1.02M | -1.11M | 143.90K | 10.40K |
| Net Income | -831.20K | 552.60K | -1.92M | -1.23M | -841.40K |
| EBIT | -949.60K | -534.20K | -1.95M | -1.41M | -937.90K |
| EBITDA | -938.40K | -523.20K | -1.87M | -1.34M | -913.10K |
| EPS Basic | -0.03 | 0.02 | -0.11 | -0.07 | -0.06 |
| Normalized Basic EPS | -0.02 | 0.03 | -0.09 | -0.04 | -0.03 |
| EPS Diluted | -0.03 | 0.02 | -0.11 | -0.07 | -0.06 |
| Normalized Diluted EPS | -0.02 | 0.03 | -0.09 | -0.04 | -0.03 |
| Average Basic Shares Outstanding | 25.60M | 23.24M | 18.16M | 17.01M | 15.09M |
| Average Diluted Shares Outstanding | 25.60M | 23.24M | 18.16M | 17.01M | 15.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |